Edwards Lifesciences Ventures

Edwards Lifesciences Ventures is the corporate venture capital arm of Edwards Lifesciences, the Irvine, California-based medical device company. The fund invests strictly in breakthrough structural heart and critical care technologies, mirroring the parent company’s strategic priorities. The investment scope is exclusively medical devices, and AI is not a declared focus.

It invests at Series A and Series B with checks of $5M to $25M, making it a meaningful participant or potential lead in larger device-focused rounds. The geographic emphasis is U.S.-anchored given the corporate base, although structural heart and critical care are global markets and relevant companies often span multiple regions.

Founders fitting Edwards Ventures’ thesis should bring deep domain expertise in cardiovascular or critical care technologies, a defensible IP position, and a credible regulatory and clinical pathway. Expect diligence to be technically rigorous, with strategic input from Edwards’ R&D and clinical leadership. The corporate strategic angle implies that potential commercial or partnership alignment with Edwards is part of the evaluation. Limited public information is available about portfolio cadence and specific recent investments.